Constantine Velentzas
Founder & Creator
Phase 1: U.S. Naval Officer Phase 2: Competitive Strategy and Commercial Leader Phase 3: Competitive Intelligence Capabilities Builder
Background
- U.S. Navy officer deployed to Europe and the Middle East post-9/11
- ~20 years in pharma: Wyeth, Pfizer, Biogen, Alexion, AstraZeneca
- U.S. and Global marketing, sales, commercial excellence, and competitive intelligence
- Significant launches in competitive spaces including Prevnar 13, Tecfidera, and Soliris/Ultomiris
CI Leadership
- Designed, built, and led Alexion's first competitive intelligence function
- Oversaw competitive intelligence across 20+ in-line and pipeline indications
- Embedded CI function within franchises as a strategic partner, not a reporting function
- Cultural impact: Systems and processes still in use at Alexion/AstraZeneca today
Pelorus Intelligence
- Capabilities span technology-enabled insight generation, traditional CI projects, and CI training/organizational design
- Custom-built software for rapid CI identification, analysis, and data/insights dissemination
- Building capabilities to eliminate administrative burden so CI teams focus on strategy
- Software also used by hedge funds to capitalize on information asymmetry for algorithmic trading
- Coverage: rare diseases, immunology, neurology, and beyond
Expert Network
Scientific Advisory
KOLs, scientists, and MDs specializing in key therapeutic areas providing clinical context, development expertise, regulatory insights, and scientific analysis.
Commercial Strategy
Current and former commercial leaders in life sciences providing strategic insights, commercial context, competitor evaluations, and other market intelligence.
Business Development
Analysts with deep biotech coverage experience who provide expertise in financing behavior, transaction dynamics, and market valuation.